Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma

NCT02585687 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped problems with enrollment

Conditions

Hepatocellular Carcinoma

Interventions

DEVICE: liver Perfusion MRI

Sponsor

Hospices Civils de Lyon